Location: Jacksonville- LaVilla (Downtown)

The purpose of this study is to determine if an AF detection intervention using a two week heart monitor in men and women at least 70 years of age with undiagnosed atrial fibrillation (AF) or atrial flutter (AFL) reduces the person-years incidence rate of stroke compared to usual care (no AF detection intervention).

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty

Condition: Heart Disease

This is a phase 2 study is evaluating drug LY3209590 safety and effectiveness compared to insulin degludec in subjects with type 1 diabetes.

Location(s): Jacksonville- LaVilla (Downtown), Macon

Condition: Diabetes

This is a Phase 2a study being done to evaluate the efficacy, safety, PK, and immunogenicity of multiple doses of MEDI3506 in adult subjects with DKD.

Location(s): Jacksonville- LaVilla (Downtown)

Condition:

This study is being done to assess the efficacy and safety of tirzepatide compared to dulaglutide in patients with type 2 diabetes and increased cardiovascular risk.

Location(s): Jacksonville- LaVilla (Downtown), Macon

Condition: Diabetes, Heart Disease

This randomized, double-blind, placebo controlled, parallel group study being done to provide data on the efficacy, safety, tolerability and pharmacokinetics of multiple dose of PF-06882961 in adults with type 2 diabetes mellitus that are inadequately controlled on metformin and/or diet and exercise.

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Macon

Condition: Diabetes

Protocol I8F-MC-GPHR(a) A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Nonalcoholic Steatohepatitis (NASH)

Location(s): Jacksonville- LaVilla (Downtown)

Condition: Nonalcoholic Steatohepatitis

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon, St. Augustine

Condition: Cholesterol, Heart Disease

A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon

Condition: Kidney Disease